glp 1 agonist risks GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Drugs and Eating Disorders:
Description
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
C., & La Fleur, S
In addition, prevention and treatment of hypoglycemia with excessive carbohydrates also contribute to weight gain
Although widespread adoption of GLP-1 and GLP-1/GIP medications has the potential to improve population health by reducing obesity-related diseases, the financial implications are considerable
Int J Obes (Lond) 2024;48(8):11181125
